Citation: | DU Dan, YANG Fan, HE Ping, CHEN Hui, ZHAO Yan, WANG Jing, LIU Haipeng, PENG Shuming. Changes of peripheral blood miR-145 level and its effect on PAI-1 in patients with repeated implantation failure[J]. Chinese Journal of General Practice, 2023, 21(7): 1143-1146. doi: 10.16766/j.cnki.issn.1674-4152.003069 |
[1] |
SAXTORPH M H, HALLAGER T, PERSSON G, et al. Assessing endometrial receptivity after recurrent implantation failure: a prospective controlled cohort study[J]. Reprod Biomed Online, 2020, 41(6): 998-1006. doi: 10.1016/j.rbmo.2020.08.015
|
[2] |
SHAULOV T, SIERRA S, SYLVESTRE C. Recurrent implantation failure in IVF: a canadian fertility and andrology society clinical practice guideline[J]. Reprod Biomed Online, 2020, 41(5): 819-833. doi: 10.1016/j.rbmo.2020.08.007
|
[3] |
FODINA V, DUDOROVA A, ERENPREISS J. Evaluation of embryo aneuploidy (PGT-A) and endometrial receptivity (ERA) testing in patients with recurrent implantation failure in ICSI cycles[J]. Gynecol Endocrinol, 2021, 37(sup1): 17-20. doi: 10.1080/09513590.2021.2006466
|
[4] |
DIENER C, KELLER A, MEESE E. Emerging concepts of miRNA therapeutics: from cells to clinic[J]. Trends Genet, 2022, 38(6): 613-626. doi: 10.1016/j.tig.2022.02.006
|
[5] |
陶中娥, 张晔. 子宫内膜异位症合并不孕患者血清miR-145表达及与临床病理类型及妊娠结局关系[J]. 中国计划生育学杂志, 2021, 29(6): 1266-1269. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202106045.htm
TAO Z E, ZHANG Y. Expression of serum miR-145 level of infertility women with endometriosis, and its association with clinicopathological type and pregnancy outcomes[J]. Chinese Journal of Family Planning, 2021, 29(6): 1266-1269. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202106045.htm
|
[6] |
LIU X M, ZHAO H S, LI W S, et al. Up-regulation of miR-145 may contribute to repeated implantation failure after IVF-embryo transfer by targeting PAI-1[J]. Reprod Biomed Online, 2020, 40(5): 627-636. doi: 10.1016/j.rbmo.2020.01.018
|
[7] |
刘美霞, 刘群会, 朱祖欣, 等. 急性脑梗死患者血清lncRNA SNHG14和miR-145-5p水平变化及其与疾病发生风险的关系[J]. 卒中与神经疾病, 2020, 27(1): 47-51, 55. doi: 10.3969/j.issn.1007-0478.2020.01.010
LIU M X, LIU Q H, ZHU Z X, et al. Serum levels of LncRNA SNHG14 and MiR-145-5p in patients with acute cerebral infarction and their relationships with risk of disease[J]. Stroke and Nervous Diseases, 2020, 27(1): 47-51, 55. doi: 10.3969/j.issn.1007-0478.2020.01.010
|
[8] |
陈曼, 夏汝斌, 林虹, 等. 反复种植失败的子宫内膜异位症患者冻融胚胎移植结局的影响因素[J]. 实用医学杂志, 2022, 38(9): 1070-1075. doi: 10.3969/j.issn.1006-5725.2022.09.006
CHEN M, XIA R B, LIN H, et al. An analysis on factors influencing the outcome of frozen-thawed embryo transfer in endometriosis patients with repeated implantation failure[J]. The Journal of Practical Medicine, 2022, 38(9): 1070-1075. doi: 10.3969/j.issn.1006-5725.2022.09.006
|
[9] |
李杨, 刘芦屏, 展照双. 立体思维在体外受精-胚胎移植反复失败辨治中的应用[J]. 世界中医药, 2022, 17(21): 3112-3115. doi: 10.3969/j.issn.1673-7202.2022.21.023
LI Y, LIU L P, ZHAN Z S. Application of Systematic Thinking in the Treatment of Repeated Failure in In-vitro Fertilization-embryo Transfer[J]. World Chinese Medicine, 2022, 17(21): 3112-3115. doi: 10.3969/j.issn.1673-7202.2022.21.023
|
[10] |
SHEIKHANSARI G, POURMOGHADAM Z, DANAⅡ S, et al. Etiology and management of recurrent implantation failure: a focus on intra-uterine PBMC-therapy for RIF[J]. J Reprod Immunol, 2020, 139(1): 103121. DOI: 10.1016/j.jri.2020.103121.
|
[11] |
BEN RAFAEL Z. Repeated implantation failure (RIF): an iatrogenic meaningless definition that generates unnecessary and costly use of add-on procedures[J]. Hum Reprod, 2020, 35(7): 1479-1483. doi: 10.1093/humrep/deaa134
|
[12] |
范洋阳, 袁宁霞, 朱丽红, 等. 血清血管细胞黏附分子-1、纤溶酶原激活物抑制物-1、血管生成素样蛋白8与妊娠期糖尿病患者妊娠结局的关系研究[J]. 现代生物医学进展, 2022, 22(9): 1724-1728. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202209025.htm
FAN Y Y, YUAN N X, ZHU L H, et al. Relationship study between serum vascular cell adhesion molecule-1, plasminogen activator inhibitor-1, angiopoietin like protein 8 and pregnancy outcome in patients with gestational diabetes mellitus[J]. Progress in Modern Biomedicine, 2022, 22(9): 1724-1728. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202209025.htm
|
[13] |
叶鸣, 方佳, 赵磊, 等. 皖南地区MTHFR和PAI-1基因多态性分布及与不良妊娠相关性研究[J]. 中国药业, 2022, 31(9): 65-68. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGZ202209015.htm
YE M, FANG J, ZHAO L, et al. Distribution of MTHFR and PAI-1 gene polymorphisms and their correlation with adverse pregnancy in Southern Anhui[J]. China Pharmaceuticals, 2022, 31(9): 65-68. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGZ202209015.htm
|
[14] |
KIM J O, AHN E H, SAKONG J H, et al. Correction to: association of miR-27aA>G, miR-423C>a, miR-449bA>G, and miR-604A>G polymorphisms with risk of recurrent implantation failure[J]. Reprod Sci, 2020, 27(4): 1086. doi: 10.1007/s43032-020-00179-6
|
[15] |
VON GROTHUSEN C, FRISENDAHL C, MODHUKUR V, et al. Uterine fluid microRNAs are dysregulated in women with recurrent implantation failure[J]. Hum Reprod, 2022, 37(4): 734-746. doi: 10.1093/humrep/deac019
|
[16] |
王晨晔, 丁彩飞, 张伟, 等. 毓麟珠方加减对反复移植失败患者非移植周期子宫内膜容受性的影响[J]. 浙江中西医结合杂志, 2020, 30(9): 716-720, 781. doi: 10.3969/j.issn.1005-4561.2020.09.006
WANG C Y, DING C F, ZHANG W, et al. Effect of Modified Yulinzhu Prescription on Endometrial Receptivity in Patients with Repeated Transplantation Failure in Non-transplantation Cycle[J]. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 2020, 30(9): 716-720, 781. doi: 10.3969/j.issn.1005-4561.2020.09.006
|
[17] |
高爽, 徐鹏, 王蓓蒂, 等. microRNA-145在子宫内膜异位症中的研究进展[J]. 中华全科医学, 2021, 19(11): 1921-1924. doi: 10.16766/j.cnki.issn.1674-4152.002201
GAO S, XU P, WANG B D, et al. Research progress of microRNA-145 in endometriosis[J]. Chinese Journal of General Practice, 2021, 19(11): 1921-1924. doi: 10.16766/j.cnki.issn.1674-4152.002201
|
[18] |
陈双华, 李荣, 周玉生. miR-145通过靶向ABCE1发挥抗乳腺癌作用[J]. 中南药学, 2022, 20(5): 1017-1022. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX202205009.htm
CHEN S H, LI R, ZHOU Y S. miR-145 exerts anti-breast cancer effects by targeting ABCE1[J]. Central South Pharmacy, 2022, 20(5): 1017-1022. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX202205009.htm
|
[19] |
杨斌, 汪嫣嫣, 甘家兵. miR-145介导TGF-β/Smad信号通路对乳腺癌患者治疗及预后的影响[J]. 实用癌症杂志, 2020, 35(12): 1950-1954. doi: 10.3969/j.issn.1001-5930.2020.12.009
YANG B, WANG Y Y, GAN J B. Effect of Mir-145-mediated TGF-β/Smad signaling pathway on the treatment and prognosis of breast cancer patients[J]. Journal of Applied Cancer, 2020, 35(12): 1950-1954. doi: 10.3969/j.issn.1001-5930.2020.12.009
|
[20] |
余兰, 藏汉青, 伟乃莲. miR-145、ABCD2评分联合动脉超声对TIA患者进展为脑梗死的风险评估价值分析[J]. 河北医科大学学报, 2021, 42(10): 1139-1143. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202110006.htm
YU L, ZANG H Q, WEI N L. Analysis of the risk assessment value of miR-145, ABCD2 score combined with arterial ultrasound for the progression of cerebral infarction after TIA attack[J]. Journal of Hebei Medical University, 2021, 42(10): 1139-1143. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202110006.htm
|
[21] |
SIROHI V K, GUPTA K, KAPOOR R, et al. MicroRNA-145 targets Smad1 in endometrial stromal cells and regulates decidualization in rat[J]. J Mol Med (Berl), 2019, 97(4): 509-522.
|
[22] |
SHEKIBI M, HENG S, WANG Y, et al. Progesterone suppresses podocalyxin partly by up-regulating miR-145 and miR-199 in human endometrial epithelial cells to enhance receptivity in in vitro models[J]. Mol Hum Reprod, 2022, 28(11): gaac034. DOI: 10.1093/molehr/gaac034.
|
[23] |
TENG F, ZHANG J X, CHEN Y, et al. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer[J]. Mol Oncol, 2021, 15(4): 1234-1255.
|
[24] |
CHEN Y, YANG C W, LI Y J, et al. MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia[J]. Biol Open, 2019, 8(11): bio044800. DOI: 10.1242/bio.044800.
|
[25] |
郭玲, 杨芳, 郭安良, 等. 体外受精-胚胎移植后反复种植失败的相关因素分析[J]. 现代妇产科进展, 2022, 31(6): 435-439, 442. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC202206007.htm
GUO L, YANG F, GUO A L, et al. Analysis of factors related to repeated implantation failure after in vitro fertilization-embryo transfer[J]. Progress in Obstetrics and Gynecology, 2022, 31(6): 435-439, 442. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC202206007.htm
|